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Background and Aims: Hypertension and obesity are important risk factors of
cardiovascular disease. They are both associated with high leptin levels and have
been shown to promote vascular hypertrophy, through the RhoA/ROCK and ERK1/2
phosphorylation. Calcineurin/NFAT activation also induces vascular hypertrophy by
upregulating various genes. This study aimed to decipher whether a crosstalk exists
between the RhoA/ROCK pathway, Ca2+/calcineurin/NFAT pathway, and ERK1/2
phosphorylation in the process of mechanical stretch-induced vascular smooth muscle
cell (VSMC) hypertrophy and leptin synthesis.
Methods and Results: Rat portal vein (RPV) organ culture was used to investigate
the effect of mechanical stretch and exogenous leptin (3.1 nM) on VSMC hypertrophy
and leptin synthesis. Results showed that stretching the RPV significantly upregulated
leptin secretion, mRNA, and protein expression, which were inhibited by the calcium
channel blocker nifedipine (10µM), the selective calcineurin inhibitor FK506 (1 nM), and
the ERK1/2 inhibitor PD98059 (1µM). The transcription inhibitor actinomycin D (0.1µM)
and the translation inhibitor cycloheximide (1mM) significantly decreased stretch-induced
leptin protein expression. Mechanical stretch or leptin caused an increase in wet weight
changes and protein synthesis, considered as hypertrophic markers, while they were
inhibited by FK506 (0.1 nM; 1 nM). In addition, stretch or exogenous leptin significantly
increased calcineurin activity and MCIP1 expression whereas leptin induced NFAT
nuclear translocation in VSMCs. Moreover, in response to stretch or exogenous leptin,
the Rho inhibitor C3 exoenzyme (30 ng/mL), the ROCK inhibitor Y-27632 (10µM), and
the actin depolymerization agents Latrunculin B (50 nM) and cytochalasin D (1µM)
reduced calcineurin activation and NFAT nuclear translocation. ERK1/2 phosphorylation
was inhibited by FK506 and C3.
Conclusions: Mechanical stretch-induced VSMC hypertrophy and leptin synthesis and
secretion are mediated by Ca2+/calcineurin/NFAT activation. RhoA/ROCK and ERK1/2
activation are critical for mechanical stretch-induced calcineurin activation.
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INTRODUCTION
Hypertension affects blood vessels of various organs, making
them stiff, less elastic, and at risk of blockage or rupture
(Lifton et al., 2001). It is a major risk factor for many
cardiovascular diseases such as aneurysms, atherosclerosis,
stroke, left ventricular hypertrophy, and vascular hypertrophy
(Intengan and Schiffrin, 2001; Kuhlencordt et al., 2001; Hoenig
et al., 2008). The force imposed by high blood pressure
mechanically stretches blood vessels circumferentially, which in
turn promotes vascular smooth muscle cell (VSMC) remodeling
in the form of hypertrophy (Zeidan et al., 2005; Shyu, 2009).
A reliable model for mimicking hypertension in vitro is to
mechanically stretch the rat portal vein (RPV), which has
spontaneous contractile activity and longitudinally-oriented
VSMCs (Sutter, 1990). This low-pressure blood vessel is sensitive
to pressure increase and undergoes hypertrophy when under
hypertensive conditions (Malmqvist and Arner, 1988, 1990;
Zeidan et al., 2000). It has also been used as an analog for small
pre-capillary resistance blood vessels (Ljung, 1990; Sutter, 1990).
Thus, mechanically stretching the RPV with a specific force that
mimics the force of stretch (See Rat Portal Vein Organ Culture)
during hypertension is a well-characterized system that mimics
hypertension in order to study the hypertrophic effect of stretch
(Zeidan et al., 2000, 2003a,b, 2005; Ren et al., 2010; Turczynska
et al., 2012).
We have previously shown that in mechanical stretch-induced
VSMC hypertrophy, G-actin levels are lowered compared to F-
actin levels due to changes in the actin cytoskeleton dynamics
via the RhoA/ROCK pathway (Zeidan et al., 2003b, 2006, 2007).
The PI3K/AKT pathway also induces changes in the actin
cytoskeleton through phosphorylation of LIMK/cofilin (Zeidan
et al., 2007). Moreover, MAP kinases, such as ERK1/2 and p38,
play a significant role in promoting VSMChypertrophy as a result
of mechanical stretch (Zeidan et al., 2000, 2003a). We have also
demonstrated that mechanical stretch induces the secretion of
the obesity-associated hormone leptin fromVSMCs (Maffei et al.,
1995) and upregulates leptin mRNA expression after 1–3 days of
stretch (Zeidan et al., 2005).
Leptin is a 16 kDa protein that is the product of the ob gene
(Zeidan and Karmazyn, 2006) and found in excessive levels in
obesity (Sinha et al., 1996). It reduces appetite and increases
energy expenditure, but also found to exert pleiotropic effects
on several physiological systems, such as the nervous, immune,
reproductive, and cardiovascular systems (Zeidan et al., 2006;
Karmazyn et al., 2008; Fernández-Riejos et al., 2010; Zuure
et al., 2013; Procaccini et al., 2014; reviewed by Ghantous et al.,
2015a). Leptin also plays a detrimental role in the development
of several obesity-associated cardiovascular diseases (Margetic
et al., 2002; Rahmouni and Haynes, 2004) such as atherosclerosis
(Schëfer et al., 2004; Schneiderman et al., 2012), left ventricular
hypertrophy (Perego et al., 2005; Zeidan et al., 2006), and vascular
hypertrophy (Zeidan et al., 2005). Several studies have shown
that hypertension is associated with high plasma levels of leptin
(Agata et al., 1997; Hiraoka et al., 1997; Stenvinkel, 2000). We
have shown that blood vessels under mechanical stretch, a model
mimicking hypertension, have the ability to produce and secrete
leptin protein (Zeidan et al., 2005; Ghantous et al., 2015b) and
leptin receptor mRNA expression (Zeidan et al., 2005). Leptin
has also been shown to activate the Ca2+/calmodulin-dependent
phosphatase calcineurin, which in turn promotes cardiomyocyte
hypertrophy (Rajapurohitam et al., 2012). However, the exact
mechanisms by which mechanical stretch induces VSMC leptin
synthesis and hypertrophy and whether calcineurin is involved in
this process have not been fully elucidated yet. We hypothesized
that calcineurin and nuclear factor of activated T cells (NFAT) are
key intermediates in this pathway.
NFAT is a family of transcription factors (NFAT 1–5; Rao et al.,
1997; Feske et al., 2003; Pang and Sun, 2009) found in the cytosol
in the phosphorylated, inactive form (Kudryavtseva et al., 2013).
Calcineurin, Ca2+/calmodulin-dependent serine/threonine
phosphatase, dephosphorylates NFAT leading to its activation
(Rao et al., 1997; Kudryavtseva et al., 2013) and translocation to
the nucleus, which activates gene transcription (Hill-Eubanks
et al., 2003). In skeletal muscle cells, NFAT upregulates
expression of genes involved in differentiation, maturation
(Delling et al., 2000), and hypertrophy (Musarò et al., 1999;
Horsley et al., 2001), whereas it promotes cardiac hypertrophy
in the heart (Molkentin et al., 1998; Bueno et al., 2002a; Fiedler
et al., 2002; Hullmann et al., 2014). In addition, NFAT mediates
VSMC proliferation (Pang and Sun, 2009; Kudryavtseva et al.,
2013), hypertrophy (Suzuki et al., 2002), and angiogenesis (Graef
et al., 2001; Gomez et al., 2002). However, the exact mechanisms
by which calcineurin/NFAT promote hypertrophy of VSMCs
have not been fully uncovered yet. Therefore, we hypothesized
that leptin and the RhoA/ROCK pathway belong to the pathway
of calcineurin/NFAT-induced VSMC hypertrophy.
To date, neither calcineurin signaling nor NFAT activation
and nuclear translocation have been linked to mechanical
stretch/leptin-mediated vascular remodeling. Accordingly, the
present study was designed to take a closer look at the
mechanisms of mechanical stretch/leptin-induced vascular
remodeling and identify the role and the interaction of the
RhoA/ROCK pathway and calcineurin/NFAT activation in this
process.
MATERIALS AND METHODS
Rat Portal Vein Organ Culture
Two hundred to two hundred fifty grams of Sprague-Dawley
male rats were euthanized by CO2, as approved by the
Animal Ethics Committee, American University of Beirut. In a
sterile environment, RPVs were dissected, divided longitudinally
into two strips, and weighed when the experiments required.
They were cultured either unloaded or loaded with 0.6 g
weights (stretch the RPV slightly above optimal length or
10% stretch) in DMEM F-12 HAM culture media with 5%
penicillin/streptomycin. The loads were mounted on the veins
using 6-0 suture silk strings to hold the weights. They were
then incubated at 37◦C, 5% CO2 in air. When leptin (Rat
Leptin, Biovision, San Francisco, USA) was used in the
experiment, a concentration of 3.1 nM was added, equivalent
to the average concentration found in obesity (Maffei et al.,
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1995). In experiments that measured changes in wet weight,
RPVs were gently blotted using filter paper and then weighed
after organ culture, and the difference between the wet
weights was calculated as previously described (Zeidan et al.,
2000).
Inhibitors such as the transcription inhibitor actinomycin
D (0.1µM; Sigma Aldrich, Missouri, USA), the translation
inhibitor cycloheximide (1mM; Sigma Aldrich, Missouri, USA),
the actin depolymerization agents cytochalasin D (1µM,
Calbiochem, California, USA), latrunculin B (50 nM, Sigma
Aldrich, Missouri, USA), the selective Rho inhibitor clostridial
toxin C3 exoenzyme (30 ng/mL, Alexis Biochemicals, Carlsbad,
California, USA), the selective ROCK inhibitor Y-27632 (10µM,
Sigma Aldrich, Missouri, USA), the selective calcineurin
inhibitor FK506 (0.1 or 1 nM, Sigma Aldrich, Missouri, USA),
the selective ERK inhibitor PD98059 (1µM, Sigma Aldrich,
Missouri, USA), and the calcium channel blocker nifedipine (1
or 10µM, Sigma Aldrich, Missouri, USA) were added to the
media 60min before mechanically stretching the RPV or adding
leptin. Following incubation, the RPV strips were taken out
of the incubator and either weighed (Zeidan et al., 2000) or
immediately frozen in liquid nitrogen and stored at −80◦C for
protein analysis.
Immunoblotting
RPVs were homogenized using lysis buffer (50mM Tris,
pH = 8.0, 150mM NaCl, 1% Nonidet-P40, 0.5% sodium
deoxycholate) and liquid nitrogen. Proteins were extracted
following centrifugation of the samples for 10min at 4◦C and
quantified using Bradford assay. Leptin protein expression and
ERK1/2 phosphorylation were determined by Western blot as
described previously (Zeidan et al., 2006). Primary antibodies for
leptin [anti-leptin antibody Ob (Y-20)], GAPDH, P-ERK1/2, and
T-ERK1/2 were added to the nitrocellulose membranes at 1:1000
ratio (3% BSA) for 1 h. All antibodies were purchased from Santa
Cruz Biotechnology, California, USA.
Protein Synthesis Measurement
RPVs were either stretched or incubated with leptin and then
treated with FK506 (0.1 or 1 nM) for 2 days. They were then
cultured for another day with [3H] leucine to measure protein
synthesis. The radioactivity of [3H]-leucine incorporation into
proteins was determined by liquid scintillation counting as
previously described (Zeidan et al., 2003b).
RNA Isolation and Real-Time PCR
RNA isolation and Real-Time PCR were done as described
previously (Zeidan et al., 2005). The primers were:
MCIP1 forward 5′-GCCCAATCCAGACAAACAGT-3′ and
MCIP1 reverse 5′-TGATTTTTGGCTTGGGTCTC-3′, leptin
forward 5′-GAGACCTCCTCCATGTGCTG-3′ and leptin
reverse 5′-CATTCAGGGCTAAGGTCCAA-3′, 18S rRNA
forward 5′-GTAACCCGTTGAACCCCATT-3′ and 18S rRNA
reverse 5′-CCATCCAATCGGTAGTAGCG-3′ which functioned
as the housekeeping gene to normalize expression.
Immunohistochemistry
To view leptin expression in RPVs, frozen sections (thickness =
5µm) were incubated in 4% formaldehyde and permeabilized
with 0.2% Triton X-100. To block non-specific binding, 1%
BSA, 0.1% Triton X-100 in PBS was added for 10min. Anti-
leptin antibody (Ob Y-20, Santa Cruz Biotechnology, California,
USA) was then added at 1:100 ratio in 1% BSA, PBS, and
0.05% Tween for 1 h. Finally, RPV sections were incubated
with Alexa 594-conjugated goat anti-rabbit secondary antibody
(1:250; Molecular Probes) for 1 h. Leptin was visualized and
images were taken using a laser confocal microscope (LSM710,
ZEN confocal software Carl Zeiss).
Determination of Leptin Release
To determine the effect of mechanical stretch on leptin release
from VSMCs, conditioned media were analyzed for leptin by a
TiterZyme enzyme immunometric assay kit (Assay Designs, Inc.,
Ann Arbor, Michigan, USA).
Calcineurin Phosphatase Activity Assay
Calcineurin activity was measured by commercially available
kits according to the instructions of manufacturer (Enzo Life
Sciences, Plymouth Meeting, Pennsylvania).
Determination of NFAT Nuclear
Translocation
To study the nuclear translocation of NFAT, Rat Aortic Smooth
Muscle Cells (RASMCs) were cultured (40 × 103 per ml) in
DMEM media with 10% fetal bovine serum for 3 days and
then starved for another day. RASMCs were then treated with
leptin (3.1 nM) with or without inhibitors. They were then
fixed with freshly prepared 4% paraformaldehyde for 10min,
washed twice with PBS, permeabilized with 0.2% Triton X-
100 in PBS with for 20min, blocked with 1% BSA, 0.1%
Triton X-100 in PBS for 10min, and washed with PBS as
described previously (Zeidan et al., 2006). They were then
incubated with NFATc3 antibody (1:100 ratio, Santa Cruz
Biotechnology, California, USA) overnight at 4◦C followed by
secondary antibody Alexa Fluor 594 goat anti-rabbit IgG (1:250
ratio, Santa Cruz Biotechnology, California, USA) for 1 h in
darkness at room temperature. To stain F-actin, Phalloidin-
Fluorescin isothiocyanate [phalloidin-(FITC); 1µg/mL, Acti-
stain 555 phalloidin, Cytoskeleton, Denver, CO, USA] was
added for 20min. VSMCs were then mounted on glass slides
using Mounting Medium (Santa Cruz Biotechnology, California,
USA) which contains the nuclear stain DAPI. NFATc3 nuclear
translocation was assessed using a laser confocal microscope
(LSM710, ZEN confocal software Carl Zeiss).
Statistical Analysis
Experimental group values were normalized to the unstretched
and untreated RPVs. Data values are presented as mean
± standard error of the mean (S.E.M). Statistical analysis
was performed using t-test or one-way analysis of variance
(ANOVA). Statistical significance was established by Holm-Sidak
or Tukey tests and considered significant for p < 0.05 between
groups.
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RESULTS
Mechanical Stretch Induces Leptin mRNA
and Protein Expression in VSMCs
We investigated the effect of mechanical stretch for 1, 3,
6, 18, and 24 h on leptin mRNA expression. Figure 1A
shows that leptin mRNA expression increased starting
1 h (60% over basal) and remained elevated at 24 h. To
ascertain whether mechanical stretch-induced leptin protein
expression was mediated by mRNA or protein synthesis,
RPVs were pre-treated with either actinomycin D (0.1µM)
or cycloheximide (1mM) and mechanically stretched for
1 h (peak of leptin protein expression), followed by Western
blot analysis or immunohistochemistry. Actinomycin D
and cycloheximide each significantly reduced mechanical
stretch-induced leptin protein expression, in comparison to
untreated stretched RPVs, as shown by both Western blot
and immunohistochemistry (Figures 1B,C). Thus, blocking
either transcription or translation significantly reduced leptin
expression in VSMCs in response to mechanical stretch,
indicating that the latter activates leptin protein synthesis at
the level of both transcription and translation after only 1 h of
stretch.
Since we have shown that stretch induces leptin release into
the medium at a peak after 3 h (Ghantous et al., 2015b), we
studied the effect of actinomycin D (0.1µM) and cycloheximide
(1 mM) on mechanical stretch-induced leptin secretion after
3 h of stretch. Both compounds significantly inhibited leptin
release into the culture medium (Figure 1D), indicating that the
secreted leptin was synthesized by the VSMCs in response to
stretch.
Role of Extracellular Ca2+ Inflow in
Mechanical Stretch-Induced VSMC
Hypertrophy and Leptin Synthesis
To investigate the role of extracellular Ca2+ on mechanical
stretch-induced RPV hypertrophy (wet weight and protein
A B
C D
FIGURE 1 | Mechanical stretch upregulates endogenous leptin protein synthesis and is dependent on leptin RNA and protein synthesis. (A) Effect of
mechanical stretch for 1, 3, 6, 18, or 24 h on the mRNA expression of leptin (n = 9–11). *p < 0.05 vs. unstretched (0min). (B) RPVs were pre-treated with the inhibitor
of transcription actinomycin D (0.1µM) or the inhibitor of translation cycloheximide (1mM), followed by mechanical stretch for 1 h (St 1 h). Proteins were extracted,
quantified, separated by SDS-PAGE, and immunoblotted using anti-leptin and anti-GAPDH antibodies. Leptin expression was normalized using GAPDH and fold
change was normalized to the unstretched RPVs. (C) Representative microscopic images (n = 4) for leptin detection in RPV wall after being mechanically stretched for
1 h and pre-treated with actinomycin D (0.1µM) or cycloheximide (1mM). Leptin primary antibody was detected by Alexa 594-conjugated secondary antibody (red).
(D) Leptin release into the extracellular media was measured using ELISA for mechanically stretched RPVs for 3 h pre-treated with actinomycin D (0.1µM) or
cycloheximide (1mM). Values are represented as mean ± S.E.M and normalized to unstretched RPVs (n = 7–9). *p < 0.05 vs. unstretched (0 min). #p < 0.05 vs. St.
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synthesis) and leptin synthesis and secretion, RPVs were
incubated in Ca2+-depleted medium with the addition of
1mM EGTA. Results showed that the hypertrophic effect of
mechanical stretch was abolished in calcium-depleted medium
(data not shown). Inhibition of Ca2+ inflow was then examined
in mechanical stretch-induced hypertrophy using nifedipine (1
or 10µM). Results showed that 10µM nifedipine significantly
inhibited mechanical stretch-induced increase in wet weight
and protein synthesis (Figures 2A,B). These findings confirm
the involvement of extracellular Ca2+ inflow in the mechanical
stretch mediated VSMC hypertrophy.
To assess the role of calcium flow on mechanical stretch-
induced leptin synthesis, RPVs were incubated for 1 h with 10
µM nifedipine followed by 1 h of stretch. Figure 2C shows that
nifedipine significantly attenuated mechanical stretch-induced
leptin expression in VSMCs. To study the effect of nifedipine
on the release of leptin in response to stretch, RPVs were
pre-treated with nifedipine and stretched for 3 h, the peak of
leptin release (Ghantous et al., 2015b). Nifedipine significantly
reduced mechanical stretch-induced leptin release into medium
(Figure 2D). These results suggest that Ca2+ inflow is required
for mechanical stretch-induced leptin synthesis and release from
VSMCs.
Mechanical Stretch/Leptin Induces
Calcineurin Activity and MCIP1 Expression
in VSMCs
We have previously established that mechanical stretch and
leptin promote VSMC hypertrophy (Zeidan et al., 2005),
similar to calcineurin (Suzuki et al., 2002). However, whether
there is a crosstalk between calcineurin and mechanical
stretch/leptin-induced VSMC hypertrophy has not been
established yet.
To study the effect of mechanical stretch on calcineurin
activation, calcineurin activity was investigated by detecting its
phosphatase activity using a commercially available kit after
RPVs were stretched for 5, 15, 30, and 60min. Calcineurin
activity was increased significantly after mechanical stretch
for 5, 15, 30, or 60min, with peak activation at 30min,
compared to unstretched RPVs (Figure 3A). To examine the
effect of exogenous leptin on calcineurin activation, RPVs were
treated with leptin (3.1 nM) for 5, 15, 30, and 60min followed
by analysis of calcineurin phosphatase activity. As shown in
Figure 3A, calcineurin activity was increased significantly by
exogenous leptin after 5, 15, 30, or 60min of treatment, with
peak calcineurin activation after 30min (Figure 3A). Calcineurin
activitation was higher in response to mechanical stretch than
to leptin. This may be due to other mediators involved in
the response to stretch, besides leptin, that are activating
calcineurin.
The modulatory calcineurin-interacting protein 1 (MCIP1)
gene is upregulated by calcineurin signaling and activation (Yang
et al., 2000; Bush et al., 2004). To study whether mechanical
stretch upregulates MCIP1 gene expression, Real-Time PCR
analysis was performed on RPVsmechanically stretched for 6, 15,
or 24 h. The mRNA expression of MCIP1 significantly increased
A B
C D
FIGURE 2 | Role of extracellular calcium in the mechanical
stretch-mediated VSMC hypertrophy and leptin release. Nifedipine (1 or
10µM) inhibits mechanical stretch-induced (A) wet weight change and (B)
protein synthesis in RPV. Nifedipine (10µM) significantly attenuated (C) leptin
synthesis and (D) release after mechanical stretch for 1 h in RPV (n = 6–8).
*p < 0.05 vs. unstretched. #p < 0.05 vs. St.
after 6, 15, and 24 h of stretch, with peak expression after
15 h (Figure 3B), further indicating mechanical stretch-induced
calcineurin activation.
To investigate whether leptin had a similar effect on MCIP1
gene expression, RPVs were treated with leptin for 6, 15, or
24 h, followed by Real-Time PCR analysis. Figure 3C reveals
that leptin also significantly increased MCIP1 mRNA expression
after 6, 15, and 24 h of leptin treatment, with peak expression
after 15 h.
Leptin Induces NFAT Nuclear Translocation
Since NFAT is activated by calcineurin (Rao et al., 1997;
Kudryavtseva et al., 2013) and is translocated to the nucleus
to activate gene expression (Hill-Eubanks et al., 2003), the
effect of leptin on NFATc3 activation and thus nuclear
translocation in RASMCs was then investigated. Cells were
treated with leptin for 15, 30, or 60min. Results showed
that NFATc3 was scattered inside the cytoplasm in untreated
RASMCs. On the other hand, leptin treatment for 15 or
30min caused a slight NFATc3 translocation to the nucleus
while leptin treatment for 60min induced full NFATc3
translocation (Figure 3D). These data indicate that leptin-
induced activation of calcineurin promotes the activation of
NFATc3.
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Involvement of the RhoA/ROCK Pathway in
Leptin/Mechanical Stretch-Induced
Calcineurin/NFAT Activation
We have previously shown the involvement of RhoA/ROCK
pathway in mechanical stretch-induced VSMC hypertrophy
(Zeidan et al., 2003b). Since calcineurin/NFAT activation
is implicated in VSMC hypertrophy (Suzuki et al., 2002)
and since mechanical stretch activates calcnineurin/NFAT, the
RhoA/ROCK pathway was then investigated for its involvement
in mechanical stretch-induced calcineurin/NFAT activation.
RPVs were pre-treated with either the selective RhoA inhibitor
C3 (30 ng/mL) or the selective ROCK inhibitor Y-27632 (10µM)
followed by mechanical stretch for 15min. Calcineurin activity
was then measured by detecting its phosphatase activity.
Treatment with either C3 or Y-27632 significantly decreased
calcineurin activity, although it remained high (Figure 4A).
When actin depolymerization agent latrunculin B (50 nM) was
used followed by stretch for 15min, the activity of calcineurin
decreased very significantly, reaching almost negative control
(unstretched) levels (Figure 4A). These results indicate that
mechanical stretch-induced activation of calcineurin is mediated
by the RhoA/ROCK pathway and requires an intact actin
cytoskeleton.
Since leptin activates calcineurin/NFAT (Figures 3A,D), the
involvement of the RhoA/ROCK pathway in calcineurin/NFAT
activation in response to leptin was then studied. Pre-treatment
with either C3 or Y-27632 followed by leptin treatment
for 15min resulted in a significant decrease in calcineurin
activity (Figure 4B). Latrunculin B followed by 15min of leptin
treatment also significantly reduced calcineurin activity, to
almost control levels (Figure 4B).
To examine the involvement of the RhoA/ROCK
pathway on NFAT activation and translocation after
leptin treatment for 1 h, Y-27632 (10µM) and the actin
depolymerization agent cytochalasin D (1µM) were used
followed by immunocytochemistry to visualize NFAT nuclear
translocation in RASMCs. Y-27632 abolished leptin-induced
NFAT translocation, as did cytochalasin D (Figure 4C). These
data indicate that the RhoA/ROCK pathway and an intact actin
cytoskeleton are required in leptin-induced calcineurin/NFAT
activation (Figures 4B,C).
Calcineurin Promotes Mechanical
Stretch/Leptin-Induced VSMC Hypertrophy
We have previously shown that mechanical stretch induces
VSMC hypertrophy and that leptin is involved in this process
(Zeidan et al., 2005; Ghantous et al., 2015b). To study
whether calcineurin is implicated in mechanical stretch-induced
VSMC hypertrophy, RPVs were pre-treated with the calcineurin
inhibitor FK506 (0.1 or 1 nM) and mechanically stretched for
3 days. Hypertrophy was assessed by wet weight changes and
protein synthesis (measured by [3H]-leucine incorporation).
Mechanical stretch alone, without FK506 addition, significantly
increased both wet weight and protein synthesis (Figures 5A,B).
On the other hand, FK506 (1 nM) alone, without stretch,
had no effect on wet weight and leucine incorporation
(Figures 5A,B). However, RPVs treated with 0.1 nM FK506
and stretched for 3 days showed reduced wet weight change
and protein synthesis, compared to stretched RPVs, whereas
1 nM FK506 resulted in a significant attenuation of hypertrophy
(Figures 5A,B). It’s important to note that the relationship
between wet and dry weights of RPVs in the different groups
showed no significant differences in the wet weight/dry weight
ratios between the different groups, demonstrating that the
increase in RPV wet weight was not due to increased water
retention (data not shown). These data suggest that calcineurin
plays a pivotal role in mechanical stretch-induced VSMC
hypertrophy.
Our previous studies revealed that leptin is implicated in
mechanical stretch-induced VSMC hypertrophy (Zeidan et al.,
2005; Ghantous et al., 2015b). To study whether calcineurin
is involved in leptin-mediated VSMC hypertrophy, exogenous
leptin (3.1 nM) was added to RPVs for 3 days with or without
FK506 (0.1 or 1 nM), followed by analysis of wet weight changes
and protein synthesis. Leptin alone significantly increased RPV
wet weight and protein synthesis (Figures 5C,D). FK506 (1
nM) alone had no effect on RPV hypertrophy (Figures 5C,D).
Treatment with both leptin and 0.1 nM FK506 reduced the
change in wet weight and protein synthesis, while 1 nM FK506
significantly attenuated VSMC hypertrophy by decreasing the
leptin-induced increase in protein synthesis and significantly
reducing wet weight change (Figures 5C,D). Thus, calcineurin is
involved in leptin-mediated VSMC hypertrophy.
Involvement of Calcineurin Activation in
Mechanical Stretch-Mediated Leptin
Synthesis and Release
To study the role of calcineurin on the expression of
leptin protein, 1 nM FK506 was used followed by mechanical
stretch for 1 h. Calcineurin inhibition by FK506 significantly
reduced mechanical stretch-induced leptin protein expression
(Figure 6A), further validating and confirming calcineurin’s role
in leptin synthesis in response to stretch.
To investigate whether the increased expression of leptin
in response to mechanical stretch was caused by the direct
production of leptin, and whether calcineurin is involved in
this process, Real-Time PCR analysis was performed to study
leptin mRNA expression after 24 h of stretch. Mechanical stretch
alone significantly upregulated leptin mRNA expression, while
0.1 nM FK506 reduced stretch-induced leptin mRNA expression
(Figure 6B). Pre-treatment with 1 nM FK506 significantly
decreased leptin mRNA expression in response to mechanical
stretch, indicating that calcineurin is involved in mechanical
stretch-induced leptin expression at the transcriptional level.
Mechanical stretch induces the release of leptin into culture
media by VSMCs after 1–3 days of stretch (Zeidan et al., 2005).
To study whether calcineurin activation affects leptin release
in response to mechanical stretch, RPVs were stretched for
3 h with or without FK506 (0.1 or 1 nM). Leptin was then
measured in the culture media using immunometric assay.
Mechanical stretch alone significantly increased leptin release
into the media (Figure 6C) whereas pre-treatment with 1 nM
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A
B C
D
FIGURE 3 | Mechanical stretch/leptin activate calcineurin/NFAT and MCIP1 gene expression. (A) RPVs were either mechanically stretched or treated with
leptin (3.1 nM) for 5, 15, 30, or 60min, followed by measuring the phosphatase activity of calcineurin, using a kit. Mechanical stretch and leptin each significantly
activated calcineurin, with peak activation after 30min (n = 8–9). *p < 0.05 vs. control. (B) RPVs were stretched for 6, 15, or 24 h followed by Real-Time PCR. MCIP1
mRNA expression was significantly increased in response to mechanical stretch. (9–10). *p < 0.05 vs. unstretched (0 h). (C) RPVs treated with leptin (3.1 nM) for 6, 15,
or 24 h significantly upregulated MCIP1 mRNA expression. (8–10). *p < 0.05 vs. unstretched (0 h). (D) Representative laser confocal microscopic images of RASMCs
to detect NFATc3 nuclear translocation. DAPI stained the nuclei (left panel; blue). NFATc3 primary antibody was detected by Alexa Fluor 594 goat anti-rabbit
secondary antibody (second panel; red). Phalloidin-FITC stained F-actin green (third panel). The overlay of all three signals is shown in the right panel (n = 4). Time
course of leptin treatment showed that 1 h of leptin treatment activated NFAT and promoted its nuclear translocation.
FK506 significantly decreased mechanical stretch-induced leptin
release, to an even greater extent than 1 nM FK506 (Figure 6C).
We have previously shown that the MAP kinase ERK1/2
is involved in mechanical stretch-induced VSMC hypertrophy
(Zeidan et al., 2000, 2003a). However, it is still unclear whether
ERK 1/2 affects leptin protein expression in response to
mechanical stretch. To study the involvement of ERK1/2 in this
process, RPVs were pre-treated with the selective ERK inhibitor
PD98059 (1 µM) and stretched for 1 h, followed by Western
blot analysis for leptin protein expression. Mechanical stretch-
induced leptin protein expression was significantly decreased
by PD98059 (Figure 6A), indicating that ERK1/2 is involved in
leptin protein expression.
Involvement of the RhoA/ROCK Pathway
and Calcineurin on Mechanical
Stretch-Induced ERK 1/2 Activation
Both calcineurin activation (Figure 3) and ERK1/2
phosphorylation are involved in mechanical stretch-induced
VSMC hypertrophy (Zeidan et al., 2000, 2003a). However,
whether there is a cross talk between these pathways in
response to mechanical stretch is unclear. To investigate this,
RPVs were pre-treated with 1 nM FK506 followed by stretch
for 10min and ERK1/2 phosphorylation was evaluated by
Western blot. Stretch alone significantly upregulated ERK1/2
phosphorylation (Figure 6D) whereas calcineurin inhibition
by FK506 significantly reduced stretch-induced p-ERK1/2
(Figure 6D), indicating that calcineurin activation is upstream
to ERK phosphorylation.
To study whether the RhoA/ROCK pathway affects ERK
1/2 phosphorylation, RPVs were treated with C3 (30 ng/mL)
and stretched for 10min. Inhibition of RhoA by C3 resulted
in a significant reduction in p-ERK1/2 by mechanical stretch
(Figure 6D), suggesting that the RhoA/ROCK pathway is
involved in mechanical stretch-mediated ERK1/2 activation.
DISCUSSION
In the present study, we investigated the involvement of Ca2+ and
the calcineurin/NFAT signaling pathway in mechanical stretch-
induced VSMC hypertrophy and leptin synthesis and secretion
in VSMCs. The major and novel findings of this study are: (1)
Ca2+ inflow is involved in mechanical stretch-mediated leptin
synthesis from VSMCs; (2) Mechanical stretch/Leptin-induced
Frontiers in Physiology | www.frontiersin.org 7 September 2016 | Volume 7 | Article 433
Soudani et al. Mechanisms of Hypertension-Induced Leptin Synthesis
A
B
C
FIGURE 4 | Calcineurin/NFAT activation is mediated by the RhoA/ROCK pathway. (A) RPVs were pre-treated with either the selective RhoA inhibitor C3
(30 ng/mL) or the selective ROCK inhibitor Y-27632 (10 µM) and mechanically stretched for 15min. Calcineurin activity was measured by detecting its phosphatase
activity. C3 and Y-27632 compound each significantly reduced calcineurin activity. The actin depolymerization agent latrunculin B (Lat-B; 50 nM) also significantly
decreased stretch-induced activation of calcineurin (n = 8). *p < 0.05 vs. unstretched. #p < 0.05 vs. St 15min. (B) C3, Y-27632, and Lat-B each significantly reduced
calcineurin activation in response to leptin (3.1 nM) treatment for 15min (n = 8). *p < 0.05 vs. untreated. #p < 0.05 vs. Lep 15min. (C) Laser confocal microscopic
images (n = 4) of RASMCs reveal that NFAT nuclear translocation in response to 1 h leptin treatment (3.1 nM) was abolished by Y-27632 compound and cytochalasin
D (Cyto D; 1µM).
activation of calcineurin promotes the nuclear translocation
of NFAT and expression of MCIP1; (3) The RhoA/ROCK
pathway and an intact actin cytoskeleton are required for
mechanical stretch/leptin-induced calcineurin activation; (4)
Calcineurin plays a pivotal role in mechanical stretch/leptin-
induced VSMC hypertrophy. These findings suggest that the
calcineurin/NFAT pathway is involved in the mechanisms that
lead to leptin synthesis in VSMCs in response to mechanical
stretch (Summarized in Figure 7).
Hypertension has been implicated in promoting vascular
hypertrophy (Malmqvist and Arner, 1988, 1990; Zeidan et al.,
2000, 2003a,b, 2005; Intengan and Schiffrin, 2001; Shyu, 2009;
Ren et al., 2010; Turczynska et al., 2012). Extensive research has
been done to decipher the mechanisms by which hypertension
induces VSMC hypertrophy. The major extracellular mediator
of hypertension-induced VSMC hypertrophy is thought to be
mechanical stretch, which activates several signaling pathways.
Among these pathways are the RhoA/ROCK pathway (Ghantous
et al., 2015b), MAPK activation (Zeidan et al., 2003a), and
ROS formation (Ghantous et al., 2015b). However, evidence
also suggests that hypertension mediates cardiac hypertrophy
through calcineurin/NFAT signaling pathways (Bueno et al.,
2002a; Takeda et al., 2002).
Recently, we have reported that mechanical stretch
significantly increases intracellular leptin levels and enhanced
leptin release in VSMCs (Ghantous et al., 2015b). In the
mechanism of mechanical stretch-mediated increase in leptin
protein expression, we hypothesized that leptin is directly
synthesized by VSMCs in response to mechanical stretch and
not pre-stored inside the cells and released upon stimulation. To
test this hypothesis, leptin mRNA synthesis (transcription) and
protein synthesis (translation) were inhibited by actinomycin
D and cycloheximide, respectively. Both inhibitors significantly
inhibited leptin protein synthesis and secretion. Our results
Frontiers in Physiology | www.frontiersin.org 8 September 2016 | Volume 7 | Article 433
Soudani et al. Mechanisms of Hypertension-Induced Leptin Synthesis
A C
B D
FIGURE 5 | Calcineurin is involved in
mechanical stretch/leptin-induced VSMC hypertrophy, assessed by
changes in wet weight and protein synthesis by measuring
[3H]-leucine incorporation. Mechanical stretch for 3 days significantly
increased RPV wet weight (A) and protein synthesis (B), while pre-treatment
with the calcineurin inhibitor FK506 (FK; 0.1 and 1 nM) reduced the
stretch-induced change in wet weight (A) and protein synthesis (B) (n = 6–8).
*p < 0.05 vs. unstretched. #p < 0.05 vs. St at 3 days. Leptin (3.1 nM)
treatment alone significantly increased wet weight (C) and protein synthesis
(D) while FK506 (0.1 and 1 nM) resulted in a reduction in hypertrophy as
evaluated by wet weight changes (C) and protein synthesis (D) (n = 6–8).
*p < 0.05 vs. untreated. #p < 0.05 vs. Lep at 3 days.
demonstrated that mechanical stretch induces mRNA and
protein synthesis of leptin in VSMCs.
Many studies have shown a clear relationship between
Ca2+ homeostasis and various VSMC functions and signaling,
including VSMC growth and contraction (Waitkus-Edwards
et al., 2002; Ren et al., 2010). Indeed, it is well-established that
Ca2+-dependent signaling molecules underlie the hypertrophic
program and contribute to the pathogenesis of vascular
remodeling. A study by Ren et al. has shown that the hypertrophic
effect of Ca2+ influx was through L-type calcium channels
in a stretched RPV. In their study, they showed that Ca2+
influx induced the expression of contractile phenotype marker
genes via the RhoA/ROCK cascade (Ren et al., 2010). Our
data demonstrate the involvement of L-type calcium channels
in mechanical stretch-induced VSMC hypertrophy and leptin
synthesis and release, as suggested by the effect of L-type calcium
channel blocker nifedipine. Indeed, our results demonstrated
that nifedipine at a low concentration of 1 µM did not
affect mechanical stretch-induced VSMC hypertrophy, whereas
a concentration of 10 µM significantly inhibited this effect.
This indicates an involvement of L-type calcium channels in
the extracellular Ca2+ influx and VSMC hypertrophy induced
by mechanical stretch. To date and to our knowledge, there
are no studies that have examined the role of L-type calcium
channels in mechanical stretch-induced leptin synthesis and
secretion from VSMCs. Interestingly, we found that 10 µM
FIGURE 6 | Calcineurin activation promotes mechanical
stretch-induced leptin production and release as well as ERK1/2
phosphorylation. (A) Leptin protein expression was evaluated using Western
blot densitometric scans and normalized to unstretched RPVs. Pre-treatment
with 1 nM FK506 (FK) followed by 1 h of mechanical stretch significantly
decreased leptin protein expression. The ERK1/2 inhibitor PD98059 (1 µM)
also significantly reduced leptin expression in response to 1 h of mechanical
stretch (n = 5–6). *p < 0.05 vs. unstretched. #p < 0.05 vs. St 1 h. (B,C) Leptin
release into the culture medium by VSMCs was measured using
immunometric assay while leptin mRNA expression was measured using
Real-Time PCR analysis. Mechanical stretch for 24 h significantly increased
leptin secretion and mRNA expression, while FK506 (FK; 0.1 and 1 nM)
reduced stretch-mediated leptin release (B) and mRNA expression (C) (n =
8–9). *p < 0.05 vs. unstretched. #p < 0.05 vs. St 24 h. (D) ERK 1/2
phosphorylation (P-ERK1/2) was evaluated by Western blot and normalized to
Total-ERK (T-ERK1/2) and to the unstretched RPVs. Mechanical stretch for
10min significantly increased P-ERK1/2 compared to unstretched RPVs.
FK506 (1 nM) and C3 (30 ng/mL) each significantly reduced ERK1/2
phosphorylation in response to 10min of mechanical stretch (n = 5). *p < 0.05
vs. unstretched. #p < 0.05 vs. St 10min.
nifedipine significantly inhibited mechanical stretch-induced
leptin synthesis and secretion from the RPV. This suggests that
an elevated intracellular Ca2+ concentration provides a major
contribution to leptin synthesis evoked by mechanical stretch.
To evaluate the downstream signaling of Ca2+ in relation
with hypertrophy and leptin synthesis in VSMCs, we investigated
the involvement of the calcineurin/NFAT pathway in this
process. Increased intracellular Ca2+ in the cytosol leads to
calcineurin activation (Crabtree, 2001; Hogan et al., 2003).
Calcineurin is a cytoplasmic Ca2+-regulated phosphatase which
has been shown to play a critical role in vascular and cardiac
remodeling (Bueno et al., 2002b). Various hypertrophic factors
including leptin (Rajapurohitam et al., 2012), pressure, and
alpha-adrenergic agonist have been shown to activate calcineurin
in cardiomyocytes [reviewed by Wilkins and Molkentin (2004)].
Indeed, increased activity of calcineurin is associated with
massive heart hypertrophy that often results in congestive heart
failure (Molkentin et al., 1998). Rauch and Loughna showed that
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FIGURE 7 | The proposed mechanism of mechanical stretch-induced VSMC hypertrophy demonstrates that the RhoA/ROCK pathway activation,
calcineurin activation, NFAT nuclear translocation, and leptin synthesis are involved in this process.
stretch-induced ERK phosphorylation in the C2C12 cell line is
mediated by calcineurin activation (Rauch and Loughna, 2008).
To our knowledge, there have been no studies investigating
the involvement of calcineurin on mechanical stretch-induced
VSMC hypotrophy and leptin synthesis. In the present study,
we observed that 10 µM nifedipine significantly inhibited
both mechanical stretch- and exogenous leptin- induced
calcineurin activation, indicating that calcineurin activation is
mediated by Ca2+ entry. Our results, obtained using both
calcineurin phosphatase activity and mRNA expression of
MCIP1, an indicator of calcineurin activity, show thatmechanical
stretch/leptin-induced VSMC hypertrophy is associated with
calcineurin activation. Rajapurohitam et al. have shown the
ability of leptin to induce calcineurin activation using cultured
neonatal rat ventricular myocytes (Rajapurohitam et al., 2012).
It is firmly established that the specific inhibitor for calcineurin
FK506 is a potent inhibitor of calcineurin activation (Martínez-
Martinez and Redondo, 2004; Roehrl et al., 2004). In this study,
we used FK506 to determine the need of calcineurin activity
in mechanical stretch-induced leptin synthesis and VSMC
hypertrophy. In agreement with this concept, we found that pre-
treatment with FK506 significantly inhibited both mechanical
stretch- and exogenous leptin-induced RPV hypertrophy. These
results suggest that calcineurin activation is a crucial step in the
action of mechanical stretch and exogenous leptin.
To further validate the above findings, we investigated the
downstream effectors of calcineurin signaling, including NFAT
transcription factor. In this study, we found that calcineurin
activity was associated with nuclear translocation of NFAT in
response to 3.1 nM leptin. Calcineurin was found to peak at
30min following initiation of mechanical stretch or addition of
leptin, followed by an increase in NFAT nuclear translocation
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as assessed by fluorescence microscopy at 60min after leptin
addition. Indeed, leptin addition for 60min promoted almost
complete translocation of NFAT into the nucleus, indicating that
leptin-induced activation of calcineurin promotes the activation
of NFAT. It is important to mention that mechanical stretch
activated calcineurin more than leptin did. Since mechanical
stretch activates a wide range of signaling pathways (Lehoux and
Tedgui, 1998; Zeidan et al., 2005; Seo et al., 2013), there may be
other mediators, besides leptin, that are activating calcineurin.
It has been previously demonstrated that calcineurin directly
dephosphorylates cytoplasmic NFAT and permits translocation
of NFAT into the nucleus (Rao et al., 1997; Kudryavtseva et al.,
2013). NFAT regulated genes have subsequently been shown
to modulate different functions of VSMCs such as myocyte
enhancer factor 2 (MEF2) and GATA-4 (Wilkins and Molkentin,
2004). Recent studies have also revealed roles for NFAT activation
in VSMC hypertrophy and proliferation induced by pulmonary
hypertension (Bierer et al., 2011; Hou et al., 2013). Moreover,
transgenic mice that overexpress active calcineurin or NFATc4
in the heart develop massive cardiac hypertrophy (Molkentin
et al., 1998). Furthermore, deletion of NFATc2 gene has been
shown to significantly inhibit pressure overload-induced heart
hypertrophy (Bourajjaj et al., 2008).
NFAT binds to GATA-4 and activates the transcription
of several hypertrophic genes (Molkentin et al., 1998; Liang
and Gardner, 1999; Saadane et al., 1999; Babu et al., 2000;
Hsieh et al., 2015). The role of GATA-4 in promoting
hypertrophy has been well-established in the cardiovascular
system (Chien et al., 1991; Saadane et al., 1999; Hsieh et al.,
2015). Indeed, several studies have shown the ability of GATA-
4 to activate several hypertrophic gene expressions like b-MHC
and c-fos (Herzig et al., 1997; Oka et al., 2006). We have
previously demonstrated that GATA-4 activation represents a
critical role for mediating mechanical stretch-induced VSMC
hypertrophy (Ghantous et al., 2015b). These data suggest
that NFAT is involved in mechanical stretch-induced GATA-4
activation.
To further explore the possible mechanisms of mechanical
stretch/leptin-induced calcineurin activation, we investigated
the involvement of the RhoA/ROCK pathway and intact
actin cytoskeleton dynamics. The importance of the Rho
family of small GTPases and the actin cytoskeleton dynamics
in controlling VSMC remodeling has long been appreciated
(Jalil et al., 2005; Nelson et al., 2005; Zeidan et al., 2006,
2007). Indeed, several studies have shown that hypertrophic
growth of cardiac and vascular cells is associated with cellular
morphological changes and increased F-actin/G-actin ratio
(Nelson et al., 2005; Zeidan et al., 2006, 2007). We have
recently shown that the RhoA/ROCK pathway is an important
mediator for mechanical stretch-induced actin cytoskeletal
dynamics leading to VSMC hypertrophy (Ghantous et al.,
2015b).
An active RhoA/ROCK pathway is characterized by an
increased F-actin/G-actin ratio. To study the effect of inhibiting
the RhoA/ROCK pathway on calcineurin activation in response
to mechanical stretch or leptin, we used the selective Rho
inhibitor clostridial toxin C3 exoenzyme, the selective ROCK
inhibitor Y-27632, and the actin depolymerization agent
latrunculin B. Our data demonstrate that all of these compounds
significantly attenuated mechanical stretch/leptin-induced
calcineurin activation, indicating that mechanical stretch/leptin-
induced activation of calcineurin ismediated by the RhoA/ROCK
pathway and requires an intact actin cytoskeleton. Moreover,
inhibiting the RhoA/ROCK pathway attenuated leptin-induced
NFAT translocation in RASMCs. Thus, in accordance with
published data, the current study demonstrated that RhoA
pathway and low G-actin/F-actin ratio mediated VSMC
hypertrophy is dependent on the calcineurin/NFAT signaling
pathway.
To further validate the above findings, the involvement
of ERK1/2 activation in mechanical stretch-induced VSMC
hypertrophy was investigated. ERK1/2 pathway has been
implicated as a positive regulator for vascular hypertrophy
(Zeidan et al., 2000). In fact, mechanical stretch and exogenous
leptin have been shown to stimulate vascular hypertrophy,
generally via ERK1/2 activation (Zeidan et al., 2000, 2005). In
this study, our results demonstrated that mechanical stretch-
induced ERK1/2 activation was attenuated by both FK506 and C3
exoenzyme. Therefore, these data indicate that calcineurin and
the RhoA/ROCK pathway mediate mechanical stretch-induced
ERK1/2 activation.
There are some limitations in this study. First, this form of
ex vivo organ culture uses an isolated blood vessel instead of an
in vivo experimental procedure. However, we used this model
to study the effect of hypertension and leptin in an isolated
setting without the effects of the central nervous system and the
effects of leptin on the sympathetic nervous system. Second, the
data acquired from a venous vessel may not necessarily reflect
those in other vascular tissues. However, the results could be
of direct application to portal hypertension, and this model of
mechanically stretching the RPV has been well-characterized
in many publications (Zeidan et al., 2000, 2003a,b, 2005; Ren
et al., 2010; Turczynska et al., 2012). The RPV has also been
used in experiments of partial occlusion in order to study the
effects of increased RPV pressure (Malmqvist and Arner, 1988,
1990).
In summary, our results, for the first time, demonstrate that
the calcineurin/NFAT pathway is involved in mechanical stretch-
induced VSMC remodeling and leptin synthesis. Moreover,
our study showed that the RhoA/ROCK pathway and intact
actin cytoskeleton are required for mechanical stretch-induced
calcineurin activation.
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